Chaudhary Anu, Leite Mara, Kulasekara Bridget R, Altura Melissa A, Ogahara Cassandra, Weiss Eli, Fu Wenqing, Blanc Marie-Pierre, O'Keeffe Michael, Terhorst Cox, Akey Joshua M, Miller Samuel I
Department of Microbiology, University of Washington, Seattle, WA 98195, USA.
Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
Curr Biol. 2016 Jul 25;26(14):1791-801. doi: 10.1016/j.cub.2016.05.003. Epub 2016 Jun 23.
Mutations in genes encoding autophagy proteins have been associated with human autoimmune diseases, suggesting that diversity in autophagy responses could be associated with disease susceptibility or severity. A cellular genome-wide association study (GWAS) screen was performed to explore normal human diversity in responses to rapamycin, a microbial product that induces autophagy. Cells from several human populations demonstrated variability in expression of a cell surface receptor, CD244 (SlamF4, 2B4), that correlated with changes in rapamycin-induced autophagy. High expression of CD244 and receptor activation with its endogenous ligand CD48 inhibited starvation- and rapamycin-induced autophagy by promoting association of CD244 with the autophagy complex proteins Vps34 and Beclin-1. The association of CD244 with this complex reduced Vps34 lipid kinase activity. Lack of CD244 is associated with auto-antibody production in mice, and lower expression of human CD244 has previously been implicated in severity of human rheumatoid arthritis and systemic lupus erythematosus, indicating that increased autophagy as a result of low levels of CD244 may alter disease outcomes.
